Researchers from @UCSCGenomics have designed an ingenious genetic mapping tool that effectively captures the diversity of the human genome, removing bias from human genotyping and allowing for improved analysis of genetic variation. #BaskinEngineering https://t.co/61WnwO0xaM
How to best manage covBTKi+BCL2i exposed R/R #CLL pts?
Check out @MCThompsonMD et al
Largest international series
n=125
ORR+PFS
CAR T 85.7% mPFS 4m
alloSCT 76.5% mPFS 11m
ncBTKi 75.0% mPFS NR
PI3Ki 40.9% mPFS 5m
CIT 31.8% mPFS 3m
Non-cov BTKi, CART promising approaches #ASH21
UCSC's annual Giving Day is here! Join me today to invest in #BaskinEngineering student organizations and faculty projects. Your gift will support inclusive student success and world-class faculty research. Together we can make a difference: https://t.co/NstOQm450P
#Give2UCSC
IT'S ON! Join us on Giving Day, a 24-hour fundraiser starting NOW. We’re helping raise $ for the Research Mentoring Internship Program (RMI) to expand our support for diversity and excellence in STEM! Visit https://t.co/SRyG2yUS6S to donate until 11:59 PM today!
#give2UCSC
Pleased to share #acalabrutinib in #Richters transformation in @TheLancetHaem
Difficult to Rx population
ORR 40%
Some durable responses seen
Well tolerated
Targeting BTK valuable
Combination + improved biomarker-driver approaches needed! #lymsm#CLL
https://t.co/zWdS0he1vo
Welcome to the @Nasdaq family, Vincera Pharma, Inc.! 🎉
Vincera Pharma, Inc. is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies.
#NasdaqListed: $VINC
Ahmed Hamdy (@theHamdy64), a member of the Baskin Engineering Dean's Council, has contributed to a paper on a new possible therapeutic strategy in severe
COVID-19 cases 👏🏼 👏🏽 👏🏿https://t.co/7dVDMPipSt